NEW YORK — Shares of cancer treatment company Juno Therapeutics Inc. jumped 46 percent in their stock market debut Friday.
Juno genetically engineers a patient's own white blood cells to find and kill cancer cells in the body. In its clinical trials, the company said the treatment showed evidence of tumors shrinking.
The Seattle-based company raised $264.5 million after selling more than 11 million shares at $24 per share. It plans to use the cash raised to continue trials and studies. The stock is listed on the Nasdaq stock market under ticker symbol "JUNO."
The stock rose $11 to close at $35, after rising as high as $39.50 earlier.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Athletic director used AI to frame principal with racist remarks in fake audio clip, police say
A high school athletic director in Maryland has been accused of using artificial intelligence to impersonate a principal on an audio recording that included racist and antisemitic comments, authorities said Thursday.
Business
Selling weight-loss and muscle-building supplements to minors in New York is now illegal
It's now illegal to sell weight-loss and muscle-building supplements to minors in New York, under a first-in-the-nation law that went into effect this week.
Business
Gusts of activity underway by friends and foes of offshore wind energy projects
Government supporters of offshore wind energy projects in New Jersey and New York are trading blows with opponents in some shore towns who say many vacationers and local residents don't want to see turbines filling the ocean horizon.
Business
Microsoft quarterly profit rises 20% as tech giant pushes to get customers using AI products
Microsoft on Thursday said its profit rose 20% for the January-March quarter as it tries to position itself as a leader in applying artificial intelligence technology to make workplaces more productive.
Business
Google parent reports another quarter of robust growth, rolls out first-ever quarterly dividend
Google's corporate parent Alphabet Inc. on Thursday released a quarterly report showing it's still reaping double-digit revenue gains from its digital advertising empire while sowing potentially lucrative new ground in artificial intelligence.
